716 related articles for article (PubMed ID: 9105707)
1. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
[TBL] [Abstract][Full Text] [Related]
2. Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-name in rats.
Boger RH; Bode-Boger SM; Gerecke U; Gutzki FM; Tsikas D; Frolich JC
Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):11-5. PubMed ID: 8713490
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide production modulates cyclosporin A-induced distal renal tubular acidosis in the rat.
Tsuruoka S; Schwartz GJ; Wakaumi M; Nishiki K; Yamamoto H; Purkerson JM; Fujimura A
J Pharmacol Exp Ther; 2003 Jun; 305(3):840-5. PubMed ID: 12626650
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
5. Human leptin stimulates systemic nitric oxide production in the rat.
Beltowski J; Wójcicka G; Borkowska E
Obes Res; 2002 Sep; 10(9):939-46. PubMed ID: 12226143
[TBL] [Abstract][Full Text] [Related]
6. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
7. Role of nitric oxide in salt and water excretion in experimental hypertension in hooded (Aguti) rats.
Mojiminiyi FB; Anigbogu CN; Sofola OA; Adigun SA
Niger Postgrad Med J; 2007 Jun; 14(2):99-104. PubMed ID: 17599104
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic NG-nitro-L-arginine methyl ester (L-NAME) on blood pressure and renal function in conscious uninephrectomized spontaneously hypertensive rats.
Reverte M; Flores O; Gallego B; Lestón A; López-Novoa JM
Can J Physiol Pharmacol; 1998 Jan; 76(1):63-7. PubMed ID: 9564550
[TBL] [Abstract][Full Text] [Related]
9. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
[TBL] [Abstract][Full Text] [Related]
10. Diuretic activity and kidney medulla AQP1, AQP2, AQP3, V2R expression of the aqueous extract of sclerotia of Polyporus umbellatus FRIES in normal rats.
Zhang G; Zeng X; Han L; Wei JA; Huang H
J Ethnopharmacol; 2010 Mar; 128(2):433-7. PubMed ID: 20083182
[TBL] [Abstract][Full Text] [Related]
11. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
[TBL] [Abstract][Full Text] [Related]
12. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
13. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: influence on the antinociceptive effect of morphine.
Smith DJ; Hawranko AA; Monroe PJ; Gully D; Urban MO; Craig CR; Smith JP; Smith DL
J Pharmacol Exp Ther; 1997 Aug; 282(2):899-908. PubMed ID: 9262357
[TBL] [Abstract][Full Text] [Related]
15. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed.
McCulloch AI; Randall MD
Br J Pharmacol; 1998 Apr; 123(8):1700-6. PubMed ID: 9605578
[TBL] [Abstract][Full Text] [Related]
17. Effect of the nonpeptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea pig ileum and colon.
Labbé-Jullié C; Deschaintres S; Gully D; Le Fur G; Kitabgi P
J Pharmacol Exp Ther; 1994 Oct; 271(1):267-76. PubMed ID: 7965724
[TBL] [Abstract][Full Text] [Related]
18. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
19. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
